DexCom

YTD

ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.

CEO

Jacob S. Leach

CEOJacob S. Leach

Employees

11,100

Employees11,100

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1999

Founded1999

Employees

11,100

Employees11,100

DXCM Key Statistics

Market cap

31.07B

Market cap31.07B

Price-Earnings ratio

31.90

Price-Earnings ratio31.90

Dividend yield

—

Dividend yield—

Average volume

3.98M

Average volume3.98M

High today

$83.66

High today$83.66

Low today

$81.39

Low today$81.39

Open price

$82.17

Open price$82.17

Volume

3.01M

Volume3.01M

52 Week high

$92.59

52 Week high$92.59

52 Week low

$56.72

52 Week low$56.72

Stock Snapshot

With a market cap of 31.07B, DexCom(DXCM) trades at $83.31. The stock has a price-to-earnings ratio of 31.90.

As of 2026-11-14, DexCom(DXCM) stock has fluctuated between $81.39 and $83.66. The current price stands at $83.31, placing the stock +2.4% above today's low and -0.4% off the high.

The DexCom(DXCM)'s current trading volume is 3.01M, compared to an average daily volume of 3.98M.

During the past year, DexCom(DXCM) stock moved between $56.72 at its lowest and $92.59 at its peak.

DXCM News

Zacks 20h

Here's Why You Should Retain DexCom Stock in Your Portfolio for Now - Zacks Investment Research

...

Simply Wall St 1d

Is DexCom Reasonably Priced After Raised Guidance And G7 Progress?

has delivered a mix of strong recent news and a complicated long term share price record, which puts the spotlight squarely on whether the current valuation lin...

Simply Wall St 2d

Pregnancy Device Approval Could Be A Big Deal For DexCom

Health Canada has approved the Dexcom G7 for use with the myLoop automated insulin delivery system powered by CamAPS FX, creating the only AID setup in Canada s...

Analyst ratings

87%

of 31 ratings

Buy

87.1%

Hold

12.9%

Sell

More DXCM News

Simply Wall St 4d

Is DexCom Still Below Fair Value As Guidance Rises And Buybacks Begin?

DexCom (DXCM) just packed several updates into one week, pairing a third quarter earnings release and higher 2026 revenue outlook with a new share repurchase pl...

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.